Metformin Hydrochloride Tablet, Extended Release
Product Images NDC 70518-4369

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Metformin Hydrochloride (NDC 70518-4369). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Remedyrepack Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Mm2 (Metformin HCl 1000mg 70518 4369 01)

This is a description for Metformin HCI tablet with 1000 mg strength. The tablets are extended-release and should not be broken, crushed, or chewed. The medication is manufactured by Lupin Pharma and repackaged by RemedyRepack Inc. It should be stored at 20-25°C, with excursions permitted to 15-30°C. The lot number, expiration date, and other details are not available in the text.*

FDA Label Image

Remedy_label (Remedy Label)

This is information about Metformin HCI tablets, with a dosage of 1000 mg. The tablets are extended-release and should not be broken, crushed, or chewed. The manufacturer is Lupin Pharma, based in Baltimore, MD. The tablets should be stored at 20-25°C (68-77°F) and protected from excessive heat and humidity. The package contains 30 tablets, and they should be kept out of reach of children. The text also includes details about the expiration date, repackaging information, and contact details for RemedyRepack Inc.*

FDA Label Image

Image (C2cc9684 Cbb0 450d 9f1f B09604d21cd0 01)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.